ADAMANTINOMATOUS AND PAPILLARY CRANIOPHARYNGIOMA - A CLINICOPATHOLOGICAL ANALYSIS

被引：0
|
作者：
CROTTY, T
SCHEITHAUER, BW
YOUNG, W
SHAW, E
MILLER, G
DAVIS, D
BURGER, P
机构：
[1] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
[2] DUKE UNIV,DURHAM,NC 27706
来源：
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 1993年 / 52卷 / 03期
关键词：
D O I：
10.1097/00005072-199305000-00271
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：328 / 328
页数：1
相关论文
共 50 条
  • [21] Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma
    Martinez-Barbera, J. P.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 (06) : 721 - 732
  • [22] BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma
    Larkin, Sarah Jane
    Preda, Veronica
    Karavitaki, Niki
    Grossman, Ashley
    Ansorge, Olaf
    ACTA NEUROPATHOLOGICA, 2014, 127 (06) : 927 - 929
  • [23] BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma
    Sarah Jane Larkin
    Veronica Preda
    Niki Karavitaki
    Ashley Grossman
    Olaf Ansorge
    Acta Neuropathologica, 2014, 127 : 927 - 929
  • [24] Comparison of central diabetes insipidus (antidiuretic hormone deficiency) and stalk effect in patients with adamantinomatous and papillary craniopharyngioma
    Feng, Ying
    Zhong, Liyong
    ACTA NEUROLOGICA BELGICA, 2024, 124 (05) : 1599 - 1604
  • [25] Analysis of KLRB1- Mediated Immunosuppressive Regulation in Adamantinomatous Craniopharyngioma
    Wei, Wei
    Hong, Tao
    JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2024,
  • [26] PROTEOMIC ANALYSIS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA REVEALS A COMPLEX NETWORK OF ECM REMODELING
    Knox, Aaron
    Medlin, Stephen
    Chee, Keanu
    Staulcup, Susan
    Prince, Eric W.
    Hankinson, Todd C.
    Mitra, Siddhartha
    NEURO-ONCOLOGY, 2024, 26
  • [27] SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
    Carreno, G.
    Boult, J. K. R.
    Apps, J.
    Gonzalez-Meljem, J. M.
    Haston, S.
    Guiho, R.
    Stache, C.
    Danielson, L. S.
    Koers, A.
    Smith, L. M.
    Virasami, A.
    Panousopoulos, L.
    Buchfelder, M.
    Jacques, T. S.
    Chesler, L.
    Robinson, S. P.
    Martinez-Barbera, J. P.
    ENDOCRINE-RELATED CANCER, 2019, 26 (03) : 355 - 366
  • [28] CHARACTERIZING THE LANDSCAPE OF STRUCTURAL VARIANTS IN ADAMANTINOMATOUS CRANIOPHARYNGIOMA
    Jomaa, Danny
    Khadka, Prasidda
    Novikov, Dana
    Condurat, Alexandra L.
    Tsai, Jessica W.
    Dubois, Frank
    Zhang, Shu
    Zhou, Kevin
    Gold, Rose
    Sousa, Cecilia
    Vogelzang, Jayne
    Prince, Eric
    Lu, Sophie
    Slivova, Veronika
    Otto, Georg W.
    Hereza, Sergi Castellano
    Ashley, David
    Cohen-Gadol, Aaron A.
    Thompson, Eric
    Beroukhim, Rameen
    Apps, John
    Martinez-Barbera, Juan Pedro
    Hankinson, Todd
    Bandopadhayay, Pratiti
    NEURO-ONCOLOGY, 2022, 24 : 14 - 14
  • [29] Adamantinomatous craniopharyngioma: moving toward targeted therapies
    Hengartner, Astrid C.
    Prince, Eric
    Vijmasi, Trinka
    Hankinson, Todd C.
    NEUROSURGICAL FOCUS, 2020, 48 (01)
  • [30] Identification and Functional Enrichment Analysis of Potential Diagnostic and Therapeutic Targets in Adamantinomatous Craniopharyngioma
    Zou, Yang-Fan
    Meng, Ling-Bing
    Wang, Qing-Qing
    He, Zhao-Kai
    Hu, Chen-Hao
    Shan, Meng-Jie
    Wang, Deng-Yuan
    Yu, Xin
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2020, 27 (01) : 55 - 68
12345